TP53 and neoplasm: We presented a directed network approach to assess the functional effects of the mutational/stress stimuli landscape of the most frequently mutated gene in human cancers, the guardian of the genome TP53, across cell lines and tumor samples as well as our in-house RNA-seq experiments in hypoxia and irradiation.